山东大学学报 (医学版) ›› 2019, Vol. 57 ›› Issue (7): 50-54.doi: 10.6040/j.issn.1671-7554.0.2019.428
• • 上一篇
王欣
WANG Xin
摘要: 近年来,基于全基因组的高通量测序技术发展迅速,由于其速度快、准确率高、成本低等优点,目前已广泛应用在临床医学的各个领域,为亚型众多、治疗复杂的淋巴瘤研究带来了革命性变化,为筛选淋巴瘤的特异性诊断标志、研究疾病的发病机制、寻找预后指标及促进新药研发起到了极大的推动作用。
中图分类号:
[1] Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors [J]. Proc Natl Acad Sci USA, 1977, 74(12): 5463-5467. [2] Maxam AM, Gilbert W. A new method for sequencing DNA [J]. Proc Nati Acad Sci, 1977, 74(2): 560-564. [3] Mardis ER. Next-generation DNA sequencing methods [J]. Annu Rev Genomics Hum Genet, 2008, 9(1): 387-402. [4] Schuster SC. Next-generation sequencing transforms todays biology [J]. Nat Methods, 2008, 5(1): 16-18. [5] Sultan M, Schulz MH, Richard H, et al. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome [J]. Science, 2008, 321(5891): 956-960. [6] Sabattini E, Bacci F, Sagramoso C, et al. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview [J]. Pathologica, 2010, 102(3): 83-87. [7] Aoki R, Karube K, Sugita Y, et al. Distribution of malignant lymphoma in Japan: Analysis of 2260 cases, 2001-2006 [J]. Pathol Int, 2008, 58(3): 174-182. [8] Taylor J, Xiao W, Abdel-Wahab O.Diagnosis and classification of hematologic malignancies on the basis of genetics [J]. Blood, 2017, 130(4): 410-423. [9] Dobashi A. Molecular pathogenesis of diffuse Large B-cell lymphoma [J]. J Clin Exp Hematop, 2016, 56(2): 71-78. [10] Gunawardana J, Chan FC, Telenius A, et al. Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma [J]. Nature Genetics, 2014, 46(4): 329-335. [11] Reddy A, Zhang J, Davis NS, et al. Genetic and functional drivers of diffuse large b cell lymphoma [J]. Cell, 2017, 171(2): 481-494. [12] Zhang J, Grubor V, Love CL,et al. Genetic heterogeneity of diffuse large B-cell lymphoma[J]. Proc Natl Acad Sci USA, 2013, 110(4): 1398-1403. [13] Mareschal S, Dubois S, Viailly PJ, et al. Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma [J]. Genes Chromosomes Cancer, 2016, 55(3): 251-267. [14] Novak AJ, Asmann YW, Maurer MJ, et al. Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphoma [J]. Blood Cancer Journal, 2015, 5(8): e346. [15] Cornish AJ, Hoang PH, Dobbins SE, et al. Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C [J]. Blood Advances, 2019, 3(1): 21-32. [16] Kridel R, Meissner B, Rogic S, et al. Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma [J]. Blood, 2012, 119(9): 1963-1971. [17] Bea S, Valdes-Mas R, Navarro A, et al. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma [J]. Proc Natl Acad Sci USA, 2013, 110(45): 18250-18255. [18] Chiron D, Di Liberto M, Martin P, et al. Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma [J]. Cancer Discovery, 2014, 4(9): 1022-1035. [19] Yang QP, Zhang WY, Yu JB, et al. Subtype distribution of lymphomas in Southwest China: Analysis of 6, 382 cases using WHO classification in a single institution [J]. Diagn Pathol, 2011, 6(1): 77. [20] Xiong J, Zhao WL. Advances in multiple omics of natural-killer/T cell lymphoma [J]. J Hematol Oncol, 2018, 11: 134. doi:10.1186/s13045-018-0678-1. [21] Jiang L, Gu ZH, Yan ZX, et al. Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma [J]. Nat Genet, 2015, 47(9): 1061-1066. [22] Palser AL, Grayson NE, White RE, et al. Genome diversity of epstein-barr virus from multiple tumor types and normal infection [J]. J Virol, 2015, 89(10): 5222-5237. [23] Peng RJ, Han BW, Cai QQ, et al. Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma [J]. Leukemia, 2018. doi:10.1038/s41375-018-0324-5. [24] Lau CC, Sun T, Ching AK, et al. Viral-human chimeric transcript predisposes risk to liver cancer development and progression [J]. Cancer Cell, 2014, 25(3): 335-349. [25] Check Hayden E. Genome sequencing: the third generation [J]. Nature, 2009, 457(7231): 768-769. |
[1] | 孙晨曦, 王永静, 李爱, 宋宁霞, 陈慧娴, 冯晓丽, 邓玉鹏, 王涓冬, 郑成云. 1例罕见成年XLP-1病例报道[J]. 山东大学学报 (医学版), 2022, 60(3): 117-120. |
[2] | 吴德沛,陈晓晨. 淋巴瘤免疫治疗的现状及展望[J]. 山东大学学报 (医学版), 2019, 57(7): 13-20. |
[3] | 周道斌,张炎. 原发性中枢神经系统淋巴瘤诊治现状及进展[J]. 山东大学学报 (医学版), 2019, 57(7): 31-39. |
[4] | 王海涛. 去势抵抗性前列腺癌精准治疗的研究进展[J]. 山东大学学报 (医学版), 2019, 57(1): 30-35. |
[5] | 谢炜星,丁金勇,陈伟健,任东成,晋大祥. 腰椎管狭窄症合并左骶髂关节弥漫性大B细胞淋巴瘤1例[J]. 山东大学学报 (医学版), 2018, 56(9): 93-96. |
[6] | 宋立锦,顾湘,李理想,李铭,左秀丽,李延青. 具核梭杆菌灌胃对大鼠肠道菌群的影响[J]. 山东大学学报 (医学版), 2018, 56(7): 7-14. |
[7] | 冯洒然,刘倩,王焱,李红,毕可红,朱传升. 系统性红斑狼疮伴发肝脾γδT细胞淋巴瘤1例并文献复习[J]. 山东大学学报 (医学版), 2018, 56(6): 87-90. |
[8] | 李文生. “良性淋巴瘤”概念的提出及其存在的可能性[J]. 山东大学学报(医学版), 2017, 55(3): 1-5. |
[9] | 赵力,李理想,陈飞雪,左秀丽,李延青. 枯草芽孢杆菌灌胃对小鼠肠道菌群的影响[J]. 山东大学学报(医学版), 2017, 55(10): 28-35. |
[10] | 韩康康,崔立伟,彭程,薛玉文,肖伟. 多浆膜腔积液、Warburg效应——弥漫性大B细胞淋巴瘤1例报告并文献复习[J]. 山东大学学报(医学版), 2016, 54(7): 80-87. |
[11] | 姚月,张捷. 鼻型结外NK/T细胞淋巴瘤合并肺部感染1例[J]. 山东大学学报(医学版), 2016, 54(11): 87-89. |
[12] | 高峰, 康白, 杨洪鸣, 赵廷坤, 曲梅花, 王金红. 皮肤T细胞淋巴瘤相关抗原5在肿瘤细胞株中的表达[J]. 山东大学学报(医学版), 2015, 53(3): 41-45. |
[13] | 张泳. 原位淋巴瘤的病理诊断及其临床意义[J]. 山东大学学报(医学版), 2014, 52(S2): 112-113. |
[14] | 仇会会1,叶丽平1,温有锋2,李丹1,宋佳1. IL-6对卵巢癌细胞bcl-2、cyclinD1和VEGF表达的影响[J]. 山东大学学报(医学版), 2014, 52(6): 17-21. |
[15] | 董珂1,蒲业迪2,刘琼1,代广霞1,李丽珍1,李颢1,王玲玲1,王鲁群1. siRNA沉默Pokemon基因抑制人非霍奇金淋巴瘤Raji细胞的增殖[J]. 山东大学学报(医学版), 2014, 52(5): 53-57. |
|